DAZN-Pro League row deepens as carriage talks drag on
DAZN-Pro League Dispute Continues DAZN's negotiations with Belgian TV operators Proximus and Telenet over carriage of Jupiler Pro League matches remain unresolved. DAZN acquired exc…
Paul Gauguin’s final self portrait—previously decried as fake—is authentic, museum concludes
Paul Gauguin's Final Self-Portrait: Authenticity Confirmed The Kunstmuseum Basel has concluded that Paul Gauguin's final self-portrait is …
Almonty Industries to acquire tungsten project in Montana, US
Almonty Industries to Acquire Tungsten Project in Montana, US Toronto-based Almonty Industries has agreed to acquire a tungsten project in…
Elon Musk's xAI Launches Grok-powered 'Grokipedia' Encyclopedia
Elon Musk's xAI Launches Grok-powered 'Grokipedia' Encyclopedia Elon Musk’s xAI startup has launched Grokipedia, a new open-source encyclo…
ServiceNow and Nvidia say their new open-source model is built for security - here's why
ServiceNow and Nvidia Introduce Open-Source Model for Enhanced Security Concerned about your business's data security? Apriel 2.0 is desig…
Building Knowledge, Not Just Structures: Redefining the Architect’s Role in Times of Uncertainty
Building Knowledge, Not Just Structures: Redefining the Architect’s Role in Times of Uncertainty Projects act as schools of construction, …
Operation Food Search urges St. Louisans to host food drives as SNAP halts benefits
Operation Food Search Urges St. Louisans to Host Food Drives The Trump administration confirmed that SNAP benefits will not be distributed…
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp.
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp. Cygnet Energy Ltd., a private exploration and production company, h…
Brookfield/Cameco-owned Westinghouse secures US nuclear construction deal
Brookfield/Cameco-owned Westinghouse Secures US Nuclear Construction Deal Westinghouse Electric, a nuclear power firm owned by Brookfield …
Novartis Q3: new drugs step up as generics squeeze Entresto - Pharmaceutical Technology
Novartis Q3 Performance Novartis' Q3 performance was driven by fast growth in recently label-expanded drugs, despite generic competition a…
GSK secures rights to Syndivia’s ADC asset for prostate cancer
GSK Secures Rights to Syndivia's ADC Asset for Prostate Cancer GSK acquires exclusive rights from Syndivia for an ADC targeting advanced p…